Iranian Journal of Nuclear Medicine

1. Biological assessment and human absorbed dose estimation of [111In]In-DTPA-antiMUC1 as a radioimmunoconjugate for breast cancer imaging

Articles in Press, Accepted Manuscript, Available Online from 29 November 2021

Hassan Yousefnia; Samaneh Zolghadri; Behrouz Alirezapour

2. Human organ absorbed dose estimation of 166Ho-BPAMD complex based on biodistribution data of male Syrian rats

Volume 27, Issue 2, Summer and Autumn 2019, Pages 87-91

Samaneh Zolghadri; Hassan Yousefnia

3. Preparation, quality control and biodistribution study of 68Ga-BPAMD: Optimized production with an in-house 68Ge-68Ga generator

Volume 26, Issue 2, Summer and Autumn 2018, Pages 82-86

Ali Rabie; Hassan Yousefnia; Samaneh Zolghadri; Mojtaba Shamsaei; Amir Reza Jalilian

4. Preparation and biodistribution assessment of low specific activity 177Lu-DOTATOC for optimization studies

Volume 24, Issue 2, Summer and Autumn 2016, Pages 85-91

Hassan Yousefnia; Masoumeh-Sadat Mousavi-Daramoroudi; Samaneh Zolghadri; Fereydoun Abbasi-Davani

5. Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma

Volume 24, Issue 1, Winter and Spring 2016, Pages 59-64

Hassan Yousefnia; Ahmad Bitarafan-Rajabi; Mir Sepehr Pedram; Samaneh Zolghadri; Ali Bahrami-Samani; Amir Reza Jalilian; Mohammad Mazidi; Amir Darbandi Azad; Mohammad Ghannadi-Maragheh

1. Biological assessment and human absorbed dose estimation of [111In]In-DTPA-antiMUC1 as a radioimmunoconjugate for breast cancer imaging

2. Human organ absorbed dose estimation of 166Ho-BPAMD complex based on biodistribution data of male Syrian rats

3. Preparation, quality control and biodistribution study of 68Ga-BPAMD: Optimized production with an in-house 68Ge-68Ga generator

4. Preparation and biodistribution assessment of low specific activity 177Lu-DOTATOC for optimization studies

5. Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma

Journal Archive